<?xml version="1.0" encoding="UTF-8"?>
<p>The lack of penetration of antiretroviral drugs in the HIV sanctuaries is mainly due to the expression of active efflux transporters (AET) on the membranes of lymphocytes [
 <xref rid="B22-pharmaceutics-10-00039" ref-type="bibr">22</xref>,
 <xref rid="B23-pharmaceutics-10-00039" ref-type="bibr">23</xref>,
 <xref rid="B24-pharmaceutics-10-00039" ref-type="bibr">24</xref>], macrophages [
 <xref rid="B25-pharmaceutics-10-00039" ref-type="bibr">25</xref>], and the cells that constitute the blood−brain (BBB) and blood−cerebrospinal fluid (BCSFB) barriers [
 <xref rid="B26-pharmaceutics-10-00039" ref-type="bibr">26</xref>,
 <xref rid="B27-pharmaceutics-10-00039" ref-type="bibr">27</xref>,
 <xref rid="B28-pharmaceutics-10-00039" ref-type="bibr">28</xref>]. The AET systems can be members of two transporter gene superfamilies [
 <xref rid="B28-pharmaceutics-10-00039" ref-type="bibr">28</xref>,
 <xref rid="B29-pharmaceutics-10-00039" ref-type="bibr">29</xref>,
 <xref rid="B30-pharmaceutics-10-00039" ref-type="bibr">30</xref>,
 <xref rid="B31-pharmaceutics-10-00039" ref-type="bibr">31</xref>]: 
 <list list-type="roman-lower">
  <list-item>
   <p>The ATP-binding cassette (ABC) gene family of active transporters requiring ATP hydrolysis for their efflux activity; and</p>
  </list-item>
  <list-item>
   <p>The solute carrier (SLC) gene family of energy-independent or secondary active efflux transporters.</p>
  </list-item>
 </list>
</p>
